Fig. 1From: Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trialPatient distribution. CONSORT diagram of the allocation and disposition of patients with limited-stage diffuse large B-cell lymphoma treated in this open-label, nonrandomized, phase 2 clinical trial (NCT 01804127)Back to article page